These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 32406532)

  • 1. Hypomagnesemia after heart transplantation or left ventricular assist device implant for end-stage heart failure.
    Racca V; Scaglione A; De Maria R; Panzarino C; Santangelo MA; Cipriani M
    Clin Transplant; 2020 Aug; 34(8):e13902. PubMed ID: 32406532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in biochemical markers between Heart-transplanted and Left Ventricular Assist Device implanted patients, during cardiac rehabilitation.
    Racca V; Castiglioni P; Panzarino C; Saresella M; Marventano I; Verde A; Oliva F; Ferratini M
    Sci Rep; 2018 Jul; 8(1):10816. PubMed ID: 30018333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mid-term survival after continuous-flow left ventricular assist device versus heart transplantation.
    Ammirati E; Oliva FG; Colombo T; Russo CF; Cipriani MG; Garascia A; Guida V; Colombo G; Verde A; Perna E; Cannata A; Paino R; Martinelli L; Frigerio M
    Heart Vessels; 2016 May; 31(5):722-33. PubMed ID: 25735775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective comparison of mid-term outcomes in patients treated with heart transplantation with advanced age donors versus left ventricular assist device implantation.
    Ammirati E; Cipriani MG; Varrenti M; Colombo T; Garascia A; Cannata A; Pedrazzini G; Benazzi E; Milazzo F; Oliva F; Gagliardone MP; Russo CF; Frigerio M
    Interact Cardiovasc Thorac Surg; 2016 Oct; 23(4):584-92. PubMed ID: 27245619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term heart transplant outcomes after lowering fixed pulmonary hypertension using left ventricular assist devices.
    Moayedifar R; Zuckermann A; Aliabadi-Zuckermann A; Riebandt J; Angleitner P; Dimitrov K; Schloeglhofer T; Rajek A; Laufer G; Zimpfer D
    Eur J Cardiothorac Surg; 2018 Dec; 54(6):1116-1121. PubMed ID: 29905775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short- and long-term effects of a cardiac rehabilitation program in patients implanted with a left ventricular assist device.
    Scaglione A; Panzarino C; Modica M; Tavanelli M; Pezzano A; Grati P; Racca V; Toccafondi A; Bordoni B; Verde A; Cartella I; Castiglioni P
    PLoS One; 2021; 16(12):e0259927. PubMed ID: 34851984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of functional capacity in patients with end-stage heart failure following implantation of a left ventricular assist device versus heart transplantation: results of the experience with left ventricular assist device with exercise trial.
    Jaski BE; Lingle RJ; Kim J; Branch KR; Goldsmith R; Johnson MR; Lahpor JR; Icenogle TB; Piña I; Adamson R; Favrot LK; Dembitsky WP
    J Heart Lung Transplant; 1999 Nov; 18(11):1031-40. PubMed ID: 10598726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamics and prognostic role of galectin-3 in patients with advanced heart failure, during left ventricular assist device support and following heart transplantation.
    Coromilas E; Que-Xu EC; Moore D; Kato TS; Wu C; Ji R; Givens R; Jorde UP; Takayama H; Naka Y; George I; Mancini D; Schulze PC
    BMC Cardiovasc Disord; 2016 Jun; 16():138. PubMed ID: 27301475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac replacement therapies: outcomes and costs for heart transplantation versus circulatory assist.
    Mishra V; Fiane AE; Winsnes BA; Geiran O; Sørensen G; Hagen TP; Gude E
    Scand Cardiovasc J; 2017 Feb; 51(1):1-7. PubMed ID: 27248460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Which advanced heart failure therapy strategy is optimal for patients over 60 years old?
    Gernhofer YK; Braun OO; Brambatti M; Bui QM; Silva Enciso J; Greenberg BH; Adler E; Pretorius V
    J Cardiovasc Surg (Torino); 2019 Apr; 60(2):251-258. PubMed ID: 30168306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing palliative care need in left ventricular assist device patients and heart transplant recipients.
    Strangl F; Ullrich A; Oechsle K; Bokemeyer C; Blankenberg S; Knappe D; Reichenspurner H; Bernhardt AM; Barten MJ; Rybczynski M
    Interact Cardiovasc Thorac Surg; 2020 Dec; 31(6):874-880. PubMed ID: 33155042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Freedom from graft vessel disease in heart and combined heart- and kidney-transplanted patients treated with tacrolimus-based immunosuppression.
    Groetzner J; Kaczmarek I; Mueller M; Huber S; Deutsch A; Daebritz S; Arbogast H; Meiser B; Reichart B
    J Heart Lung Transplant; 2005 Nov; 24(11):1787-92. PubMed ID: 16297783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Left Ventricular Device Implantation Impacts on Hospitalisation Rates, Length of Stay and Out of Hospital Time.
    Prichard R; Kershaw L; Goodall S; Davidson P; Newton P; McNeil F; Homer T; Hayward C
    Heart Lung Circ; 2018 Jun; 27(6):708-715. PubMed ID: 28888837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Copeptin in Heart Failure, Post-Left Ventricular Assist Device and Post-Heart Transplantation.
    Zabarovskaja S; Hage C; Gabrielsen A; Mellbin L; Lund LH
    Heart Lung Circ; 2017 Feb; 26(2):143-149. PubMed ID: 27523461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. End-stage heart failure: Two surgical approaches with different rehabilitative outcomes.
    Racca V; Castiglioni P; Panzarino C; Oliva F; Perna E; Ferratini M
    PLoS One; 2017; 12(10):e0185717. PubMed ID: 28972991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of Iron Deficiency and Iron Administration in Left Ventricular Assist Device and Heart Transplantation Patients.
    Veenis JF; Radhoe SP; Roest S; Caliskan K; Constantinescu AA; Manintveld OC; Brugts JJ
    ASAIO J; 2022 Jul; 68(7):899-906. PubMed ID: 34643575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables.
    John R; Pagani FD; Naka Y; Boyle A; Conte JV; Russell SD; Klodell CT; Milano CA; Rogers J; Farrar DJ; Frazier OH
    J Thorac Cardiovasc Surg; 2010 Jul; 140(1):174-81. PubMed ID: 20447659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of infection among left ventricular assist device recipients on post-transplantation outcomes: A retrospective review.
    Lerman DT; Hamilton KW; Byrne D; Lee DF; Zeitler K; Claridge T; Gray J; Minamoto GY
    Transpl Infect Dis; 2018 Dec; 20(6):e12995. PubMed ID: 30199584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exercise performance in patients with end-stage heart failure after implantation of a left ventricular assist device and after heart transplantation: an outlook for permanent assisting?
    de Jonge N; Kirkels H; Lahpor JR; Klöpping C; Hulzebos EJ; de la Rivière AB; Robles de Medina EO
    J Am Coll Cardiol; 2001 Jun; 37(7):1794-9. PubMed ID: 11401113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes after heart transplantation in sensitized patients bridged with ventricular assist devices.
    Fraser CD; Zhou X; Magruder JT; Suarez-Pierre A; Lui C; Grimm JC; Higgins R; Kilic A
    J Card Surg; 2019 Jun; 34(6):474-481. PubMed ID: 31045281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.